SAMPLE	VAF_MAD	VAF_median	N_mutations	MATH_score	N_Mutations_TMB	TMB	EXOME_ID	WXS	TCRseq	Sample_Name	Iniciais	RGH	Conc.DNA	Treatment.Protocol	Response1	Response2	Response3	Age	Gender	CEA.inicial	Distance.from.anal.verge	Tumor.size	Baseline.T	Baseline.N	Final.Clinical.Stage	Initial.Staging	Avoid.TME..1.yes..2.no.	Very.good.response..1.yes..2.no.	Systemic.dissemination..1.yes..2.no.	Staging.after.QRT	Disease.free..1.no..2.yes.	Follow.up	Data.diag	ultimo.seg	obs
ROP-1-ExC85-xgenV2_S7	0.17650353	0.25	385	70.601412	385	11.28	ROP-1	Y	X	TCROP1rep_v1	IBB	68070	256.5	nCRT	nCRT-R	nCRT-R	Not-Metastatic	83	F	1.9	3cm	5cm	3	0	2	T3N0	1	1	2	CCR	1	VC	26/12/2007	23/06/2012	recidiva pélvica
ROP-100-ExC85-xgenV2_S67	0.168808836	0.4375	205	38.5848768	205	6.01	ROP-100	Y	Y	TCROP56_v1	EVM (correto EMV)	14053140F	679.2	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	57	F	2.5	5cm	5cm	2	0	1	T2N0	2	1	2	ypT2N0	2	VS	27/05/2013	13/06/2019	
ROP-102-ExC85-xgenV2_S68	0.196281414	0.4	217	49.0703535	217	6.36	ROP-102	Y	Y	TCROP57_v1	MS	14059885H	1409.9	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	71	F	2.4	5cm	5cm	3	1	3	T3N2	2	2	2	ypT3N2	1	MC	05/08/2013	02/08/2016	
ROP-103-ExC85-xgenV2_S69	0.169223964	0.39823	251	42.4940270697838	251	7.35	ROP-103	Y	Y	TCROP58_v1	JSM	86282	716.2	TNT	nCRT-R	nCRT-R	Not-Metastatic	73	M	1.7	2cm	4.5cm	2	0	1	T2N0M0	1	1	2	CCR	2	VS	09/08/2013	27/04/2018	
ROP-105-ExC85-xgenV2_S70	0.091068705	0.450225	124	20.2273763118441	124	3.63	ROP-105	Y	Y	TCROP59_v1	GDS	14074652H	504.1	nCRT	nCRT-R	nCRT-R	Not-Metastatic	47	F	1.0	5cm	5cm	3	1	3	T3N1	2	1	2	ypT0N0	2	VS	02/12/2013	26/08/2022	 Reconfecção da anastomose colorretal e lesão de ureter
ROP-107-ExC85-xgenV2_S71	0.042936096	0.20968	5801	20.4769629912247	5801	169.98	ROP-107	Y	Y	TCROP60_v1	AB	859575	789.2	TNT	nCRT-R	nCRT-R	Not-Metastatic	59	M	5.1	1cm	8cm	3	1	3	T3N2M0	1	1	2	CCR	2	VS	06/01/2014	01/06/2021	
ROP-108-ExC85-xgenV2_S72	0.15218889	0.43709	270	34.8186620604452	270	7.91	ROP-108	Y	Y	TCROP61_v1	MLSS	2755577H	2670.5	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	67	F	21.4	8cm	6cm	3	1	3	T3N1	2	2	2	ypT3N1b	2	VS	13/01/2014	12/03/2021	 Protocolo adjuvancia FLOX
ROP-109-ExC85-xgenV2_S73	0.224769573	0.307915	226	72.9972794440024	226	6.62	ROP-109	Y	Y	TCROP62_v1	MCPS	14082521D	750.4	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	62	F	22.2	6cm	7cm	3	0	2	T3N0	2	2	2	ypT3N0	1	VC	10/02/2014	01/09/2022	recivida vaginal  28/08/2018  Exenteração Pélvica Total 
ROP-11-ExC85-xgenV2_S8	0.19933557	0.31111	335	64.0723763299155	335	9.82	ROP-11	Y	Y	TCROP2_v1	FG	13834966I	111.5	nCRT	nCRT-R	nCRT-R	Not-Metastatic	73	M	79.3	7cm	5cm	3	1	3	T3N1	2	1	2	PCR	2	VS	25/08/2008	19/09/2011	
ROP-110-ExC85-xgenV2_S74	0.129512523	0.40561	256	31.9303081778063	256	7.5	ROP-110	Y	Y	TCROP63_v1	MAC	51043	870.2	nCRT	nCRT-R	nCRT-R	Not-Metastatic	80	F	2.3	3cm	2cm	2	0	1	T2N0M0	1	1	2	CCR	2	VS	10/02/2014	20/06/2018	
ROP-112-ExC85-xgenV2_S75	0.271716102	0.3554	205	76.4536021384356	205	6.01	ROP-112	Y	Y	TCROP64_v1	AM	13993582G	1790	nCRT	nCRT-R	nCRT-R	Not-Metastatic	66	M	2.7	6cm	7cm	3	1	3	T3bN1	1	1	2	CCR	2	VS	05/03/2012	16/11/2015	
ROP-113-ExC85-xgenV2_S76	0.091654332	0.46067	147	19.8958760066859	147	4.31	ROP-113	Y	X	TCROP65_v1	APP	4196563	563.9	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	72	F	3.6	7cm	xx	3	1	3	T3N1	2	2	1	ypT3N2	1	VC	07/05/2019	20/09/2022	meta hepatica
ROP-114-ExC85-xgenV2_S77	0.158882829	0.381475	202	41.6496045612425	202	5.92	ROP-114	Y	Y	TCROP66_v1	ARA	06/07/2015 14141659E	1.333	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	72	M	2.6	4cm	5cm	3	1	3	T3N1	2	2	2	ypT3N1a	2	MS	06/07/2015	30/01/2020	
ROP-115-ExC85-xgenV2_S78	0.155435784	0.4153	180	37.4273498675656	180	5.27	ROP-115	Y	Y	TCROP67_v1	CLNL	CLNL190719 14246475A	5452	nCRT	nCRT-R	nCRT-R	Not-Metastatic	38	F	2.92	2cm	4cm	2	0	1	T2N0	1	1	2	ypT0	2	VS	19/07/2019	22/07/2022	HBP
ROP-117-ExC85-xgenV2_S80	0.240077418	0.41872	297	57.3360283721819	297	8.7	ROP-117	Y	Y	TCROP69_v1	EF	4164912	630.5	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	65	M	xx	10cm	xx	3	1	3	T3N1	2	2	2	ypT3N0	1	VC	25/03/2019		
ROP-119-ExC85-xgenV2_S82	0.185606694	0.382825	240	48.4834308104225	240	7.03	ROP-119	Y	Y	TCROP71_v1	EPC	14011408J	1460.8	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	47	F	145.0	5cm	5cm	3	1	3	T3N2			1	xx	1	MC	02/07/2012	08/10/2013	meta fígado, pulmão, SNC. Não operou primário
ROP-12-ExC85-xgenV2_S9	0.177556176	0.419035	208	42.3726361759758	208	6.09	ROP-12	Y	Y	TCROP3_v1	SRB	13852443C	672.6	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	63	M	0.9	3cm	6cm	3	1	3	T3N1	2	2	2	ypT3N1	1	MC	05/01/2009		
ROP-128-ExC85-xgenV2_S90	0.0461829899999999	0.4794	159	9.6334981226533	159	4.66	ROP-128	Y	Y	TCROP79_v1	JFPA	14020751K	1256.8	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	55	M	23.8	2cm	2cm	3	1	3	T3N2M1			1	xx	1	MC	13/08/2012	29/10/2012	meta hepática, faleceu logo - não foi operado - Fez RT em agosto/12 na BP e única reavaliação no prontuário é uma TC de outubro "Espessamento parietal difuso do retossigmóide, com aspecto de lesão expansiva lobulada no reto. Associam-se linfonodomegalias mesorretais. "
ROP-129-ExC85-xgenV2_S91	0.100549932	0.442415	218	22.7275142117695	218	6.39	ROP-129	Y	Y	TCROP80_v1	JGC	859663	1118	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	63	M	xx	2cm	xx	3	0	2				1		1	MC	15/01/2014	04/04/2015	não foi operado por progressão de doença ou recusa de cirurgia - Tratou no AC Camargo. Falei com esposa por tel
ROP-133-ExC85-xgenV2_S95	0.087792159	0.1813	528	48.423694980695	528	15.47	ROP-133	Y	N		JRQP	190024108	973	TNT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	53	M	xx	4cm	4cm	3	1		T3N1	2	2	2	ypT3N1	2	VS	07/06/2019		
ROP-14-ExC85-xgenV2_S10	0.22350195	0.352145	240	63.4687273708274	240	7.03	ROP-14	Y	X	TCROP4_v1	JJP	71742	77.8	nCRT	nCRT-R	nCRT-R	Not-Metastatic	49	M	2.1	0cm	4cm	3	0	2	T3N0	2	1	2	ypT0N0M	2	VS	25/03/2009	06/10/2010	Operou em Taubaté nov/2009 completa patológica
ROP-15-ExC85-xgenV2_S11	0.210581091	0.379795	258	55.4459882304928	258	7.56	ROP-15	Y	Y	TCROP5_v1	ADF	13869630D	515.3	nCRT	nCRT-R	nCRT-R	Not-Metastatic	59	M	10.6	3cm	5cm	3	0	2	T3N0	1	1	2	CCR	2	VS	13/04/2009	09/09/2021	
ROP-16-ExC85-xgenV2_S12	0.121632504	0.19969	313	60.9106635284691	313	9.17	ROP-16	Y	Y	TCROP6_v1	MI	13870297A	588.1	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	74	M	58.3	7cm	5cm	3	1	3	T3N1	2	2	2	ypT3N0	2	MS	2013?	31/03/2015	ca de próstata concomitante, RDT para os 2 tumores 7400cGy
ROP-17-ExC85-xgenV2_S13	0.264807186	0.3142	213	84.2798173138129	213	6.24	ROP-17	Y	N		JCFS	13873341C	250.3	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	43	M	3.6	3cm	3cm	3	0	2	T3N0	2	2	1	ypT4N2Mx	1	MC	11/05/2009	19/11/2013	recidiva sistêmica
ROP-18-ExC85-xgenV2_S14	0.145843362	0.375	285	38.8915632	285	8.35	ROP-18	Y	N		AFS	13700988B	231.3	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	67	F	135.9	5cm	3cm	3	0	2	T3N0	2		2	recusou cirurgia	1	MC	14/05/2009	04/02/2011	recusou cirurgia
ROP-19-ExC85-xgenV2_S15	0.211908018	0.32374	323	65.4562358682894	323	9.46	ROP-19	Y	Y	TCROP9_v1	MAS	13873114F	239.5	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	65	F	1769.0	4cm	1cm	4	1	3	T4N1	2	2	1	pT3pN1pMX	1	MC	18/05/2009	01/08/2010	recidiva SNC
ROP-20-ExC85-xgenV2_S16	0.193167954	0.398725	218	48.4464114364537	218	6.39	ROP-20	Y	X	TCROP10_v1	RGFM	72151	257.6	TNT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	42	F	xx	2cm	5cm	4	1	3	T4N1	2	2	2	ypT3N0M0	2	MS	19/05/2009	10/06/2015	Óbito por outras causas que não o câncer
ROP-24-ExC85-xgenV2_S18	0.067888254	0.46491	141	14.6024507969284	141	4.13	ROP-24	Y	N		EPX	13884961F	418.5	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	65	M	66.7	5cm	5cm	3	1	3	T3N1	2	2	1	ypT3N0Mx	2	MS	03/08/2009	19/11/2011	meta hepática operada
ROP-32-ExC85-xgenV2_S23	0.209091078	0.43664	240	47.8863773360205	240	7.03	ROP-32	Y	Y	TCROP15_v1	IFM	13772788B	285.1	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	70	F	1.6	7cm	3cm	2	0	1	T2N0	2		2	recusou cirurgia	1	VC	09/11/2009	13/08/2012	Ca reto a 6m da borda anal em 2009, QRT até março/11 e abandonou tratamento. Retornou set/11, RNM com "espessamento difuso do reto". RNM 05/12 "piora do espessamento".
ROP-33-ExC85-xgenV2_S24	0.225147636	0.43925	269	51.2572876494024	269	7.88	ROP-33	Y	Y	TCROP16_v1	LMR	13897422E	534.9	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	52	F	68.5	7cm	4cm	4	1	3	T4N1	2	2	2	ypT4N0	1	MC	09/11/2009	31/08/2010	
ROP-34-ExC85-xgenV2_S25	0.081706086	0.47603	153	17.1640623490116	153	4.48	ROP-34	Y	Y	TCROP17_v1	NT	4084343E	60.4	nCRT	nCRT-R	nCRT-R	Not-Metastatic	46	M	3.1	5cm	5cm	3	1	3	T3N1	2	1	2	ypT0N0M0	2	VS	16/11/2009	17/09/2021	Completa patológica
ROP-36-ExC85-xgenV2_S26	0.174739236	0.466195	238	37.4820055985157	238	6.97	ROP-36	Y	X	TCROP18_v1	MSBJ	13900769A	465.8	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	37	F	1.6	5cm	5cm	3	1	3	T3N1	2	2	2	ypT3N0Mx	1	MC	30/11/2009	22/01/2015	recidva local
ROP-37-ExC85-xgenV2_S27	0.21505113	0.32058	237	67.0818921953958	237	6.94	ROP-37	Y	Y	TCROP19_v1	ASS	13874170I	49.4	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	73	F	225.3	4cm	8cm	3	0	2	T3N0	2	2	1	ypT3N0	1	MC	30/11/2009	22/02/2011	meta pulmonar pré cirurgia
ROP-38-ExC85-xgenV2_S28	0.111654606	0.44574	211	25.0492677345538	211	6.18	ROP-38	Y	Y	TCROP20_v1	ARS	13900780D	604.4	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	46	F	86.7	3cm	7cm	4	0	2	T4N0	2	2	2	ypT4N0Mx	1	MC	30/11/2009	16/06/2015	recidiva local
ROP-42-ExC85-xgenV2_S29	0.122410869	0.24158	164	50.670945028562	164	4.81	ROP-42	Y	Y	TCROP21_v1	JAB	13905493G	189	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	64	F	1.1	5cm	3cm	3	1	3	T3N1	2	2	1	ypT3N1MX	1	MC	01/02/2010	04/05/2021	meta hepatica, pulmonar, peritoneal e pelvica lateral
ROP-44-ExC85-xgenV2_S30	0.167192802	0.4235	245	39.4788198347107	245	7.18	ROP-44	Y	Y	TCROP22_v1	ONO	13914315J	1583	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	58	M	xx	6cm	5cm	3	1	3	T3N1	2	2	2	ypT3N2pMx	2	MS	29/03/2010	03/04/2010	óbito por outras causas - perioperatório
ROP-45-ExC85-xgenV2_S31	0.213887289	0.297015	284	72.0122852381193	284	8.32	ROP-45	Y	N		SSR	13918812f	461.1	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	71	F	10.7	7cm	5cm	3	1	3	T3N1	2	2	2	ypT3N0pMX	2	VS	10/05/2010	08/09/2022	
ROP-46-ExC85-xgenV2_S32	0.157274208	0.22209	278	70.8155288396596	278	8.15	ROP-46	Y	N		LLS	13924222H	176	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	52	F	151.7	8cm	6cm	4	0	2	T4Nx	2	2	1	ypT4N0M1	1	MC	14/06/2010	03/12/2015	carcinomatose
ROP-47-ExC85-xgenV2_S33	0.23224929	0.39891	217	58.2209746559375	217	6.36	ROP-47	Y	N		JMA	13917038I	165	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	55	M	2.3	10cm	2cm	3	1	3	T3N1	2	2	2	ypT0N1bMX	1	MC	14/06/2010	18/08/2015	
ROP-50-ExC85-xgenV2_S34	0.0509273099999999	0.49132	76	10.3654054384108	76	2.23	ROP-50	Y	Y	TCROP26_v1	MP	13925744H	332.6	TNT	nCRT-R	nCRT-R	Metastatic	47	F	6.1	4cm	4cm	3	1	3	T3N1	1	1	1	CCR	1	VC	24/06/2010	04/12/2012	meta pulmonar
ROP-51-ExC85-xgenV2_S35	0.190595643	0.297695	278	64.023797174961	278	8.15	ROP-51	Y	Y	TCROP27_v1	MCMS	13923983J	866.6	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	66	F	10.6	5cm	5cm	3	0	2	T3N0	2	1	2	ypT2N0MX	1	MC	22/07/2010	24/10/2011	sarcoma de utero sincronico
ROP-53-ExC85-xgenV2_S36	0.138452601	0.21464	316	64.5045662504659	316	9.26	ROP-53	Y	Y	TCROP28_v1	JSSA	13932392I	333.4	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	44	F	29.6	3cm	5cm	3	1	3	T3N1	2	2	2	ypT4Nx irressecável	1	MC	19/08/2010	07/02/2013	
ROP-54-ExC85-xgenV2_S37	0.18176676	0.27049	291	67.1990683574254	291	8.53	ROP-54	Y	Y	TCROP29_v1	JGB	13932755B	389.2	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	62	M	5.2	10cm	6cm	3	0	2	T3N0	2	2	2	não operou	1	MC	02/09/2010	20/10/2011	alto risco cirúrgico
ROP-56-ExC85-xgenV2_S38	0.206541006	0.333025	266	62.0196699947451	266	7.79	ROP-56	Y	Y	TCROP30_v1	SJS	13937644G	275	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	55	M	5.2	7cm	4cm	2	1	3	T2N1	2	1	2	ypT2N0MX	2	VS	22/09/2010	08/11/2016	
ROP-57-ExC85-xgenV2_S39	0.032409636	0.14505	1001	22.3437683557394	1001	29.33	ROP-57	Y	Y	TCROP31_v1	MAGS	110016735	1804.6	TNT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	50	F	10.7	6cm	4cm	3	1	3	T3N1	2	2	2	ypT2N1M0	2	VS	06/10/2010	03/12/2013	
ROP-58-ExC85-xgenV2_S40	0.211611498	0.339155	258	62.3937426840235	258	7.56	ROP-58	Y	Y	TCROP32_v1	AMAS	13936743I	389.4	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	64	F	1.7	7cm	5cm	2	1	3	T2N1	2	2	2	ypT2ypN1b	2	MS	14/10/2010	24/05/2019	teve alta em 2017 e retornou com lesão vaginal (AP não distinguiu entre novo primário e recidiva local)
ROP-59-ExC85-xgenV2_S41	0.168705054	0.427645	202	39.4497898958248	202	5.92	ROP-59	Y	Y	TCROP33_v1	MCRS	3146202D	1029.4	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	58	F	4.8	3cm	4cm	3	1	3	T3N1	2	1	1	ypT2N0	1	MC	28/10/2010	26/03/2018	meta SNC
ROP-60-ExC85-xgenV2_S42	0.145428234	0.42732	274	34.0326298792474	274	8.03	ROP-60	Y	Y	TCROP34_v1	ARF	13942487H	968.3	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	64	M	89.7	4cm	4cm	4	1	3	T4N1	2		1	xx	1	MC	08/11/2010	01/09/2011	meta pulmonar e SNC, não operou
ROP-61-ExC85-xgenV2_S43	0.204554322	0.28412	121	71.9957489793045	121	3.55	ROP-61	Y	X	TCROP35_v1	CCO	13946717H	399.1	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	46	M	31.3	3cm	4cm	3	1	3	T3N1	2	1	2	ypT2N0	2	VS	27/12/2010	26/04/2012	
ROP-65-ExC85-xgenV2_S44	0.091046466	0.16667	309	54.6267870642587	309	9.05	ROP-65	Y	X	TCROP36_v1	STI	13953078D	459.3	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	50	M	2.5	xx	xx	3	1	3	T3N1	2	2	2	ypT3N0	2	VS	21/02/2011	31/05/2019	
ROP-68-ExC85-xgenV2_S45	0.1919967	0.24828	311	77.3307153214113	311	9.11	ROP-68	Y	X	TCROP37_v1	AMC	2134017F	1426.3	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	62	F	1.7	4cm	3cm	3	1	3	T3N1	2	2	2	ypT2N1	2	VS	18/04/2011	12/09/2022	recidiva local e amputação em 2013
ROP-69-ExC85-xgenV2_S46	0.199787763	0.422325	260	47.306638962884	260	7.62	ROP-69	Y	X	TCROP38_v1	CRSL	55732416A	423.7	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	53	F	32.9	5cm	7cm	2	0	1	T2N0	2	1	2	ypT2N0	2	VS	27/06/2011	12/09/2019	
ROP-70-ExC85-xgenV2_S47	0.179809728	0.38866	237	46.2640168785056	237	6.94	ROP-70	Y	Y	TCROP39_v1	ASN	13976645I	3365.4	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	77	M	27.6	8cm	7cm	3	0	2	T3N0	2	1	1	ypT2N0	2	VS	22/08/2011	28/09/2021	nódulos hepáticos ablados no intraoperatório, sem recidiva
ROP-71-ExC85-xgenV2_S48	0.075330906	0.478565	122	15.740997774597	122	3.57	ROP-71	Y	N		LFMF	13976435I	654.8	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	60	F	5.5	0cm	6cm	3	1	3	T3N2	2	1	1	ypT2N0	1	MC	22/08/2011	30/09/2014	meta hepatica
ROP-73-ExC85-xgenV2_S49	0.120520554	0.45146	215	26.6957325122934	215	6.3	ROP-73	Y	X	TCROP41_v1	MSGSM	110026054	355.4	TNT	nCRT-NR	nCRT-NR Metastatic	Metastatic	56	F	xx	7cm	2.5cm	3	1	3	T3N1	2	2	1	ypT2N2Mx	2	VS	08/09/2011	11/10/2018	Meta hepática em 07/14 (SO e QT)
ROP-75-ExC85-xgenV2_S50	0.115309215	0.369615	230	31.1971145651556	230	6.74	ROP-75	Y	N		ILV	110027898	187.6	TNT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	70	M	xx	0cm	13cm	4	1	3	T4N2	2	2	2	ypT3N2	2	VS	28/09/2011	13/09/2012	
ROP-76-ExC85-xgenV2_S51	0.199565373	0.437705	202	45.5935785517643	202	5.92	ROP-76	Y	Y	TCROP42_v1	NV	110025854	759.6	TNT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	66	F	xx	3cm	3cm	3	1	3	T3N1	2	2	2	ypT3N0Mx	2	MS	03/10/2011	26/10/2012	óbito por outras causas
ROP-78-ExC85-xgenV2_S52	0.19607385	0.29515	261	66.4319329154667	261	7.65	ROP-78	Y	Y	TCROP43_v1	OO	110031062	340.9	TNT	nCRT-NR	nCRT-NR Metastatic	Metastatic	70	M	xx	4cm	5cm	2	0	1	T2N0	2	2	1	ypT3N1Mx	1	MC	31/10/2011	03/06/2015	óbito meta hepática - WW regrowth com 11 meses
ROP-81-ExC85-xgenV2_S53	0.146458641	0.220375	26	66.4588274532048	26	0.76	ROP-81	Y	Y	TCROP44_v1	ESN	12/0126019	616.3	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	51	M	xx	6cm	xx	4	1	3	T4N1	2	2	1	ypT3N2M1	1	VC	26/01/2012	21/06/2013	meta hepatica
ROP-83-ExC85-xgenV2_S54	0.068837118	0.35484	8517	19.3994808927968	8517	249.57	ROP-83	Y	Y	TCROP45_v1	ND	14000951D	1504.4	nCRT	nCRT-R	nCRT-R	Not-Metastatic	60	M	20.4	7cm	4cm	3	1	3	T3N1	2	1	2	ypT0N0M0	2	VS	02/04/2012	01/02/2014	
ROP-85-ExC85-xgenV2_S55	0.143752896	0.37386	221	38.4509966297545	221	6.48	ROP-85	Y	Y	TCROP46_v1	SLM	5087878C	1100.3	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	82	M	4.0	5cm	6cm	2	0	1	T2N0	2	1	2	ypT2N0	2	MS	23/04/2012	08/03/2013	IAM
ROP-86-ExC85-xgenV2_S56	0.083781726	0.475005	160	17.6380724413427	160	4.69	ROP-86	Y	Y	TCROP47_v1	MFAM	82499	148.9	TNT	nCRT-R	nCRT-R	Not-Metastatic	54	F	2.4	1cm	7cm	2	0	1	T2N0	1	1	2	CCR	2	VS	11/05/2012	12/12/2018	
ROP-89-ExC85-xgenV2_S57	0.197815905	0.3205	374	61.7210312012481	374	10.96	ROP-89	Y	X	TCROP48_v1	MMBS	82983	770.7	TNT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	68	F	xx	0cm	4cm	3	1	3	T3N1	2	1	2	ypT2N0M0	2	VS	25/05/2012	05/09/2014	
ROP-90-ExC85-xgenV2_S58	0.036145788	0.16935	2707	21.343837023915	2707	79.32	ROP-90	Y	Y	TCROP49_v1	SARO	83284	436.9	nCRT	nCRT-R	nCRT-R	Not-Metastatic	62	M	3.0	4cm	5cm	3	1	3	T3N1	1	1	2	CCR	2	VS	06/08/2012	17/12/2018	
ROP-91-ExC85-xgenV2_S59	0.2394399	0.27309	38	87.6780182357465	38	1.11	ROP-91	Y	N		DC	14013556E	1507.7	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	67	M	2339.0	5cm	8cm	3	1	3	T3N1	2	2	2	ypT3N1c	1	MC	20/08/2012	26/09/2015	
ROP-92-ExC85-xgenV2_S60	0.188319852	0.31933	281	58.9734293677387	281	8.23	ROP-92	Y	N		MAS	13948091H	696.5	nCRT	nCRT-NR	nCRT-NR Metastatic	Metastatic	73	F	59.7	3cm	4cm	2	1	3	T2N1	2	1	1	ypT2N0	2	VS	10/01/2011	14/12/2017	teve meta hepatica
ROP-93-ExC85-xgenV2_S61	0.194050101	0.37023	224	52.4133919455474	224	6.56	ROP-93	Y	N		AZ	83712	114.3	TNT	nCRT-R	nCRT-R	Not-Metastatic	36	M	1.57	6cm	8cm	3	1	3	T3N1	1	1	2	CCR	2	VS	20/09/2012	22/03/2019	
ROP-94-ExC85-xgenV2_S62	0.18732651	0.29032	239	64.5241492146597	239	7	ROP-94	Y	Y	TCROP51_v1	CJG	14021941A	565.4	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	63	M	8.3	1cm	6cm	3	0	2	T3N0	2	2	2	ypT3N0	1	MC	24/09/2012	23/10/2019	
ROP-95-ExC85-xgenV2_S63	0.240744588	0.305975	288	78.6811301576926	288	8.44	ROP-95	Y	Y	TCROP52_v1	MGS	13984841I	229.6	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	62	F	18.5	3cm	4cm	3	1	3	T3N2	2	2	2	ypT3N2	1	MC	24/09/2012	30/09/2015	recidiva pélvica pré-sacral. Linfoma concomitante
ROP-96-ExC85-xgenV2_S64	0.06352941	0.48864	110	13.0012708742633	110	3.22	ROP-96	Y	Y	TCROP53_v1	MRN	120026954	499.5	TNT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	57	M	1.67	5cm	3cm	3	1	3	T3N1	2	2	2	ypT2N2	2	VS	22/09/2012	03/10/2017	
ROP-97-ExC85-xgenV2_S65	0.199839654	0.38889	235	51.3871927794492	235	6.89	ROP-97	Y	Y	TCROP54_v1	BAB	14029189F	502.7	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	47	F	24.1	7cm	4cm	3	0	2	T3N0	2	2	2	ypT3N0	2	VS	12/11/2012	13/02/2021	
ROP-98-ExC85-xgenV2_S66	0.175072821	0.416865	188	41.9974862365514	188	5.51	ROP-98	Y	Y	TCROP55_v1	MLSF	14034860A	167.1	nCRT	nCRT-NR	nCRT-NR Not-Metastatic	Not-Metastatic	61	F	3.3	6cm	5cm	3	1	3	T3N2	2	2	2	ypT3N2	2	VS	25/02/2013	25/05/2022	
